{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:56:02Z","timestamp":1790715362474,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":79,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clinsp.2025.100630","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T16:45:11Z","timestamp":1745426711000},"page":"100630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A systematic review and meta-analysis of the efficacy and safety of glucocorticoids in the treatment of severe pneumonia"],"prefix":"10.1016","volume":"80","author":[{"given":"Jingye","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7476-4471","authenticated-orcid":false,"given":"Zhiqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinsp.2025.100630_bib0001","first-page":"56","article-title":"Clinical aspects and prognostic factors of severe pneumonia","volume":"18","author":"Yi","year":"2008","journal-title":"Chin J Nosocomiol"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100630_bib0002","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.emc.2018.07.001","article-title":"Community-acquired pneumonia","volume":"36","author":"Rider","year":"2018","journal-title":"Emerg Med Clin North Am"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100630_bib0003","first-page":"499","article-title":"Risk factors and prognostic factors analysis of elderly patients with severe pneumonia","volume":"16","author":"Chen","year":"2011","journal-title":"J Clin Pulm Med"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100630_bib0004","first-page":"86","article-title":"Effects of bronchoscopic aspiration combined with alveolar lavage on therapeutic effect, CPIS score and serum inflammatory indexes of patients with severe pneumonia complicated with respiratory failure","volume":"62","author":"Zhang","year":"2022","journal-title":"Shandong Med J"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100630_bib0006","first-page":"380","article-title":"Analysis of pathogens and risk factors for death in elderly patients with severe pneumonia","volume":"29","author":"Fei","year":"2019","journal-title":"Chin J Nosocomiol"},{"issue":"10","key":"10.1016\/j.clinsp.2025.100630_bib0007","first-page":"63","article-title":"Clinical efficacy of the addition and subtraction of the Xiaoqinglong decoction in treating severe pneumonia in the elderly and its impact on immune function and serum IFN-\u03b3, IL-1\u03b2, and PCT levels","volume":"36","author":"Zhang","year":"2018","journal-title":"J Sichuan Tradit Chin Med"},{"issue":"7","key":"10.1016\/j.clinsp.2025.100630_bib0011","first-page":"795","article-title":"Clinical trial of glucocorticoid on adjuvant therapy of severe mycoplasma pneumoniae pneumonia in children","volume":"37","author":"Sun","year":"2021","journal-title":"Chin J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.clinsp.2025.100630_bib0012","first-page":"1507","article-title":"Clinical effect of low dose glucocorticoid on severe CAP and its effect on serum MCP-1 and NGAL levels","volume":"25","author":"Peng","year":"2020","journal-title":"J Clin Pulm Med"},{"issue":"8","key":"10.1016\/j.clinsp.2025.100630_bib0013","first-page":"71","article-title":"Clinical analysis of glucocorticoid adjuvant therapy for severe mycoplasmal pneumonia in children","volume":"27","author":"Xu","year":"2019","journal-title":"China Med. Eng."},{"issue":"28","key":"10.1016\/j.clinsp.2025.100630_bib0014","first-page":"11","article-title":"Clinical effect of glucocorticoid on severe pneumonia and its effect on procalcitonin","volume":"11","author":"Xu","year":"2018","journal-title":"Chin J Clin Ration Drug Use"},{"issue":"9","key":"10.1016\/j.clinsp.2025.100630_bib0015","first-page":"1307","article-title":"Efficacy of glucocorticoids in the treatment of severe community-acquired pneumonia","volume":"30","author":"Li","year":"2017","journal-title":"J Med Theory Pract"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100630_bib0016","first-page":"138","article-title":"Therapeutic effect of glucocorticoids on severe community-acquired pneumonia in elderly patients","volume":"14","author":"Li","year":"2020","journal-title":"Chin J Mod Drug Appl"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100630_bib0017","first-page":"47","article-title":"Clinical value of corticosteroids in treatment of elderly patients with severe community-acquired pneumonia and its effect on the level of C-reactive protein","volume":"26","author":"Chu","year":"2018","journal-title":"Clin Res"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100630_bib0018","first-page":"106","article-title":"Effect of glucocorticoid-assisted treatment of severe mycoplasma pneumoniae pneumonia in children","volume":"43","author":"Chen","year":"2023","journal-title":"Clin Med"},{"issue":"23","key":"10.1016\/j.clinsp.2025.100630_bib0019","first-page":"4464","article-title":"Effects of glucocorticoid on pulmonary function, serum inflammatory factors and humoral immune function in children with Mycoplasma Pneumoniae pneumonia","volume":"20","author":"Han","year":"2020","journal-title":"Prog Mod Biomed"},{"issue":"9","key":"10.1016\/j.clinsp.2025.100630_bib0020","first-page":"1637","article-title":"Clinical effect of inhaled budesonide auxiliary treatment for children with mycoplasma pneumoniae pneumonia","volume":"22","author":"Huang","year":"2017","journal-title":"J Clin Pulm Med"},{"issue":"11","key":"10.1016\/j.clinsp.2025.100630_bib0008","first-page":"1571","article-title":"A discussion of glucocorticoid on the regulation of inflammation in severe pneumonia","volume":"31","author":"Xu","year":"2018","journal-title":"J Med Theory Pract"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100630_bib0009","first-page":"449","article-title":"Glucocorticoids in the treatment of severe sepsis and septic shock","volume":"11","author":"Annane","year":"2005","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100630_bib0010","first-page":"42","article-title":"Pathogenic bacteria distribution and drug sensitivity tests for patients with community-acquired pneumonia","volume":"23","author":"Li","year":"2018","journal-title":"J Clin Pulm Med"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225000560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225000560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:56:56Z","timestamp":1790711816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593225000560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":19,"alternative-id":["S1807593225000560"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100630","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of the efficacy and safety of glucocorticoids in the treatment of severe pneumonia","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100630"}}